Target intelligence / Profile preview

Human adenovirus 37 (HAdV-37)

Target
HAdV-37
Molecular classification
Virus, Adenoviridae, Mastadenovirus
01

Overview

Human adenovirus 37 (HAdV-D37) is a non-enveloped, double-stranded DNA virus belonging to the species Human mastadenovirus D. It is a primary causative agent of epidemic keratoconjunctivitis (EKC), a severe and highly contagious ocular infection characterized by inflammation of the conjunctiva and cornea. Unlike many other adenoviruses that use the coxsackie-adenovirus receptor (CAR), HAdV-D37 primarily attaches to host cells by binding to sialic acid-containing glycans (specifically GD1a) via the knob domain of its fiber protein. This interaction is a key target for the development of entry inhibitors, such as sialic acid mimetics and glycosaminoglycan (GAG) mimetics like suramin. Beyond ocular disease, HAdV-D37 is also associated with genital infections and has been linked to adipogenesis and obesity in experimental models. Currently, there are no FDA-approved antivirals specifically for HAdV-D37, and clinical management often relies on off-label use of broad-spectrum DNA polymerase inhibitors like cidofovir.

Other names
HAdV-D37Ad37Adenovirus serotype 37Human mastadenovirus D serotype 37
02

Mechanism of action

Inhibition of viral DNA polymerase; Inhibition of viral attachment to host cell receptors; Inhibition of viral protease and egress

03

Biological functions

Viral attachmentViral entryViral replicationLytic cycleImmune evasion
04

Disease associations

InfectionEpidemic keratoconjunctivitisConjunctivitisKeratitisUrethritisObesity
05

Safety considerations

Nephrotoxicity associated with systemic cidofovirOcular irritation from topical treatmentsDevelopment of antiviral resistanceSpecies-specific drug efficacy
06

Interacting drugs

Cidofovir

5 more in the full profile.

07

Biomarkers

Viral DNA loadViral titerCytopathic effectSub-epithelial infiltrates

Beyond the preview

Go deeper on Human adenovirus 37 (HAdV-37).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human adenovirus 37 (HAdV-37).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call